These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1147 related items for PubMed ID: 16299727

  • 41. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
    Avazova D, Kurbanov F, Tanaka Y, Sugiyama M, Radchenko I, Ruziev D, Musabaev E, Mizokami M.
    J Med Virol; 2008 Feb; 80(2):217-24. PubMed ID: 18098129
    [Abstract] [Full Text] [Related]

  • 42. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C.
    Fang Y, Teng X, Xu WZ, Li D, Zhao HW, Fu LJ, Zhang FM, Gu HX.
    J Med Virol; 2009 May; 81(5):826-35. PubMed ID: 19319940
    [Abstract] [Full Text] [Related]

  • 43. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 44. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM.
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [Abstract] [Full Text] [Related]

  • 45. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.
    Nebbia G, Garcia-Diaz A, Ayliffe U, Smith C, Dervisevic S, Johnson M, Gilson R, Tedder R, Geretti AM.
    J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185
    [Abstract] [Full Text] [Related]

  • 46. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A.
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [Abstract] [Full Text] [Related]

  • 47. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis.
    Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T.
    J Viral Hepat; 2009 Apr; 16(4):259-64. PubMed ID: 19222745
    [Abstract] [Full Text] [Related]

  • 48. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS, Kim HS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Kim DJ, Lee MS, Park CK, Jeong BH, Kim YS, Jang MK.
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [Abstract] [Full Text] [Related]

  • 49. Molecular characterization of hepatitis B virus (HBV) isolates, including identification of a novel recombinant, in patients with acute HBV infection attending an Irish hospital.
    Laoi BN, Crowley B.
    J Med Virol; 2008 Sep; 80(9):1554-64. PubMed ID: 18649329
    [Abstract] [Full Text] [Related]

  • 50. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 51. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC, Scudamore CH, Di Bisceglie AM, Tabor E.
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [Abstract] [Full Text] [Related]

  • 52. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.
    Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G.
    Transfusion; 2007 Oct; 47(10):1794-802. PubMed ID: 17880603
    [Abstract] [Full Text] [Related]

  • 53. High levels of serum hepatitis B virus DNA in patients with 'anti-HBc alone': role of HBsAg mutants.
    Launay O, Masurel J, Servant-Delmas A, Basse-Guérineau AL, Méritet JF, Laperche S, Sogni P, Rosenberg AR.
    J Viral Hepat; 2011 Oct; 18(10):721-9. PubMed ID: 21914087
    [Abstract] [Full Text] [Related]

  • 54. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.
    N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938
    [Abstract] [Full Text] [Related]

  • 55. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.
    Zaaijer HL, Torres P, Ontañón A, Ponte LG, Koppelman MH, Lelie PN, Hemert FJ, Boot HJ.
    J Med Virol; 2008 Aug 01; 80(8):1344-9. PubMed ID: 18551607
    [Abstract] [Full Text] [Related]

  • 56. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
    Song EY, Yun YM, Park MH, Seo DH.
    Intervirology; 2009 Aug 01; 52(2):57-62. PubMed ID: 19401629
    [Abstract] [Full Text] [Related]

  • 57. Hepatitis B virus genetic diversity.
    Echevarría JM, Avellón A.
    J Med Virol; 2006 Aug 01; 78 Suppl 1():S36-42. PubMed ID: 16622876
    [Abstract] [Full Text] [Related]

  • 58. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX.
    J Infect; 2009 May 01; 58(5):383-8. PubMed ID: 19329189
    [Abstract] [Full Text] [Related]

  • 59. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
    Bian ZQ, Hua ZL, Yan WY, Liu MQ, Wu DY, Zheng ZX.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 14; 86(10):681-6. PubMed ID: 16681927
    [Abstract] [Full Text] [Related]

  • 60. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: overt and occult infection.
    Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M.
    J Med Virol; 2011 Nov 14; 83(11):1876-84. PubMed ID: 21915860
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.